Caredx Inc (CDNA) Stock: A Look at the Monthly Trend

In the past week, CDNA stock has gone up by 2.78%, with a monthly gain of 53.84% and a quarterly surge of 90.48%. The volatility ratio for the week is 7.05%, and the volatility levels for the last 30 days are 8.87% for Caredx Inc The simple moving average for the past 20 days is 26.71% for CDNA’s stock, with a 133.61% simple moving average for the past 200 days.

Is It Worth Investing in Caredx Inc (NASDAQ: CDNA) Right Now?

The 36-month beta value for CDNA is also noteworthy at 1.67. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for CDNA is 49.37M, and at present, short sellers hold a 7.05% of that float. The average trading volume of CDNA on August 15, 2024 was 860.80K shares.

CDNA) stock’s latest price update

Caredx Inc (NASDAQ: CDNA) has seen a rise in its stock price by 0.12 in relation to its previous close of 28.12. However, the company has experienced a 2.78% gain in its stock price over the last five trading sessions. zacks.com reported 2024-08-09 that CareDx (CDNA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company’s fundamentals for clues.

Analysts’ Opinion of CDNA

Craig Hallum, on the other hand, stated in their research note that they expect to see CDNA reach a price target of $15. The rating they have provided for CDNA stocks is “Buy” according to the report published on May 01st, 2024.

Stephens gave a rating of “Overweight” to CDNA, setting the target price at $10 in the report published on November 09th of the previous year.

CDNA Trading at 57.14% from the 50-Day Moving Average

After a stumble in the market that brought CDNA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -0.98% of loss for the given period.

Volatility was left at 8.87%, however, over the last 30 days, the volatility rate increased by 7.05%, as shares surge +55.71% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +106.02% upper at present.

During the last 5 trading sessions, CDNA rose by +3.12%, which changed the moving average for the period of 200-days by +464.90% in comparison to the 20-day moving average, which settled at $22.72. In addition, Caredx Inc saw 134.60% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at CDNA starting from Seeto Reginald, who sale 2,818 shares at the price of $6.91 back on Oct 02 ’23. After this action, Seeto Reginald now owns 479,164 shares of Caredx Inc, valued at $19,483 using the latest closing price.

Seeto Reginald sale 2,819 shares at $9.49 during a trade that took place back on Sep 05 ’23, which means that Seeto Reginald is holding 481,982 shares at $26,762 based on the most recent closing price.

Stock Fundamentals for CDNA

Current profitability levels for the company are sitting at:

  • -0.26 for the present operating margin
  • 0.64 for the gross margin

The net margin for Caredx Inc stands at -0.54. The total capital return value is set at -0.2. Equity return is now at value -47.66, with -32.53 for asset returns.

Based on Caredx Inc (CDNA), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at -0.47.

Currently, EBITDA for the company is -82.08 million with net debt to EBITDA at 1.11. When we switch over and look at the enterprise to sales, we see a ratio of 4.79. The receivables turnover for the company is 4.49for trailing twelve months and the total asset turnover is 0.64. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.09.

Conclusion

In summary, Caredx Inc (CDNA) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts